Explore our advanced pharmacogenomics screening services
📄 View Full Catalog
The INNOPHARMA platform is a high-throughput platform and European reference in early drug discovery. Recognized as one of the high-capacity centers of the European Research Infrastructure Consortium ERIC EU-OPENSCREEN.
INNOPHARMA offers a wide range of capabilities covering all stages of the early drug discovery process - from target identification to preliminary safety and toxicity assessment.
It builds upon over 25 years of accumulated experience by the BioFarma group through ongoing programs, involving the testing of hundreds of thousands of compounds and dozens of biological targets, as well as the development, automation, and implementation of hundreds of assays within fully integrated early discovery cascades.
This work has enabled seventeen New Chemical Entities (NCEs) to advance to clinical trials through successful public-private collaborations.